Home › Post-COVID Conditions (Long COVID) › Kansas
Post-COVID Conditions (Long COVID) clinical trials in Kansas
3 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in Kansas.
Cities in Kansas
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- University of Kansas Medical Center, Fairway
RecruitingPhase 3
All ages · All sexes · Updated Jun 23, 2026 · NCT03808922Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine
- Invivyd Investigative Site, Overland Park
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 49 · All sexes · Updated Jun 17, 2026 · NCT07655180Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
- ICON Clinical Research: Lenexa, Lenexa
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · Men · Updated Aug 27, 2025 · NCT07093580From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.